Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint Genomics Forms Pharmacogenomics Collaboration with Moffitt Cancer Center

NEW YORK, March 29 (GenomeWeb News) - DNAPrint Genomics said today that it has formed a pharmacogenomics collaboration with the H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida.


The partnership, said DNAPrint, will focus on developing and implementing new tests for predicting patient response to various cancer chemotherapies.


A primary area of focus for the effort will be colorectal cancer, the company said, although other cancers will explored.


The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.